The adoption of technology from Cuba presents an opportunity for Vietnam to access and master advanced pharmaceutical manufacturing processes, reducing dependence on imports, especially in the field of biologics and biotechnology, which is the trend in the global pharmaceutical industry. At the same time, this path will enhance the research and development capabilities of Vietnam’s pharmaceutical industry. Through the Genfarma project, Vietnamese people will also have the opportunity to access high-quality medicines at reasonable costs, especially cancer treatments.
Panorama of the working session between the high-ranking delegation of Cuba and Genfarma factory, Hoa Lac High-tech Park, Hanoi
|
Following the initial directions from the leaders of both countries, the parties have actively discussed, worked, organized factory and laboratory visits, and exchanged expertise. With relentless efforts, the project has made significant progress in a short period.
In May 2025, a joint venture agreement was signed between BioCubaFarma SA (Cuba) and Vietnamese enterprises, and just three months later, the project took shape with modern infrastructure and a complete organization.
The Cuban partner is BioCubaFarma, the Cuban national pharmaceutical group. The group has 51 subsidiaries, 9 joint ventures abroad, 6 of which have production facilities. BioCubaFarma boasts a high-quality team of experts, including 268 doctors and 1,265 masters; 21 organizations for science, technology, and innovation, with 396 R&D projects; owns 2,300 patents and 760 registration certificates in 53 countries. Currently, BioCubaFarma operates 164 production lines, including 11 abroad, exporting more than 300 products to over 40 countries, and has transferred technology to Brazil, India, Venezuela, Algeria, China, Russia, Iran, and Vietnam…
With the close and comprehensive cooperation between the pharmaceutical industries of the two countries, the Genfarma project will enhance drug security and promote biotechnology in Vietnam while opening doors for Cuban biotechnology and pharmaceuticals to reach their full potential and advance into the world market.
Mr. Miguel DÃaz-Canel, First Secretary of the Communist Party of Cuba, President of the Republic of Cuba |
Speaking during the Genfarma factory tour on the afternoon of August 31st, Mr. Miguel DÃaz-Canel, First Secretary of the Communist Party of Cuba and President of the Republic of Cuba, stated that biologics and biotechnology are areas in which Cuba has achieved remarkable success.
“The technology transfer will bring mutual benefits and boost the production of essential medicines for the people of both Vietnam and Cuba,” emphasized Mr. Miguel DÃaz-Canel.
Mr. Miguel DÃaz-Canel, First Secretary of the Communist Party of Cuba, President of the Republic of Cuba, and Comrade Dao Hong Lan, Minister of Health, on their visit to the Genfarma factory on August 31st |
From the Vietnamese Ministry of Health, Minister Dao Hong Lan also underlined the project’s positive significance. This is a concrete step towards realizing the consensus reached between the leaders of the two countries during the visit to Cuba in September 2024 by Mr. To Lam, General Secretary of the Central Committee of the Communist Party of Vietnam. The Ministry of Health has accompanied the enterprises from the initial stages of cooperation. “The Ministry of Health is ready to further promote cooperation with the Ministry of Public Health of Cuba for the health of the people of both countries. The Genfarma project is a testament to the special friendship and strong bond between our two nations, and it is even more meaningful as it commences during the 65th anniversary of the establishment of Vietnam-Cuba diplomatic relations,” emphasized Minister Dao Hong Lan.
Reporting at the reception for the high-ranking Cuban delegation and the delegation of Vietnamese ministries, the leader of Genfarma expressed sincere gratitude to the First Secretary of the Communist Party of Cuba and President of the Republic of Cuba and the leaders of the Party, State, and ministries, especially the Ministry of Public Security, Ministry of Health, Ministry of Construction, Ministry of Foreign Affairs, and the Embassy of Vietnam in Cuba, for their attention, support, and trust in entrusting this important task.
“Genfarma, together with its partner BioCubaFarma, is committed to dedicating all resources to accelerate progress and bring products to market quickly, aiming for long-term sustainability,” the Genfarma leader pledged.
Hanh Nguyen
– 15:02 01/09/2025
“Danang Land Sets a New Price Benchmark”
The Danang land market has been on an upward trajectory since early 2025, and this trend continues to the present day.
Vietnam is the Cheapest Country for Expats for the 5th Year Running.
“With its reasonable cost of living, Vietnam continues to top the charts as one of the most affordable countries in the world, according to InterNations’ latest survey. Expats have praised the country for offering a high quality of life at a fraction of the cost of other nations. From affordable accommodation to inexpensive dining options and low transportation fees, Vietnam presents an attractive proposition for those seeking a financially manageable yet enriching expat experience.”
Dr. Nguyen Thi Phuong Thao: A Tribute to Her Daily Revolutionary Impact on Vietnam
Dr. Nguyen Thi Phuong Thao, a prominent figure in Vietnam’s private sector, delivered a speech at the grand ceremony celebrating the inauguration and groundbreaking of 80 landmark projects nationwide, commemorating the country’s 80th anniversary.
Latest ACB Bank Interest Rates for September 2025: Best Rates for 12-Month Online Deposits
In September 2025, ACB introduces an attractive interest rate for individual customers who opt for online deposits with a tenure of 12 months and above.
Unlocking Profits: The Construction Plastics Division’s Soaring Success
In Q2 of 2025, the construction plastics industry continued its stellar performance, with both BMP and NTP announcing record-breaking profits.
